Eam Global Investors LLC Immuno Gen, Inc. Transaction History

Eam Global Investors LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$3.75 - $20.05 $820,410 - $4.39 Million	218,776 New	218,776 $4.13 Million
Q2 2018 Aug 03, 2018	SELL	$9.52 - $12.15 $1.35 Million - $1.72 Million	-141,737 Closed	0 $0
Q1 2018 Jun 04, 2018	BUY	$6.7 - $12.95 $949,637 - $1.84 Million	141,737 New	141,737 $1.49 Million

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Eam Global Investors LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Global Investors LLC with notifications on news.